Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Discover Job Opportunities at Merck | Merck Careers
Explore current job opportunities at Merck. Learn more about careers in Business Support, Clinical, Engineering, Information Technology, Research & Development, Manufacturing and Marketing.
Company fact sheet - Merck.com
Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. View the list of products marketed in the U.S.
Who we are - Merck.com
Merck aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
Products list - Merck.com
Merck Patient Assistance Program provides certain Merck medicines and adult vaccines for free to qualified patients. Merck Access Program Information about insurance coverage and financial assistance options for eligible patients. Clinical trials Learn about our clinical trials and find available studies. Merck Manuals
Research - Merck.com
How Merck scientists are driving next-generation cancer research. Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth
Our Q3 2024 financial results - Merck.com
Oct 31, 2024 · Merck’s Q3 2024 financial results represent strong progress across the business and our diverse pipeline. Our company announced worldwide sales of $16.7 billion, an increase of 4% from Q3 2023.
Merck Announces Third-Quarter 2024 Financial Results
Oct 31, 2024 · RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2024. “Our third-quarter results were strong, as we continue to make progress heading into 2025 and beyond," said Robert M. Davis, chairman and chief executive officer, Merck.
History - Merck.com
Learn how Merck has created a legacy of inventing medicines and vaccines and become a leading global biopharmaceutical company over the past 130 years.
Investor relations - Merck.com
Jan 6, 2025 · Merck’s (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide sales of $15.8 billion, an increase of 9% from Q1 2023. “Merck has begun 2024 with continuing momentum in our business.